News
CSL Behring Advocacy Grants Include Alpha-1 Foundation
King of Prussia, PA — CSL Behring announced grants totaling more than $90,000 to patient advocacy organizations in the United States. The seven grants represent the latest round of awards in the company’s Local Empowerment for Advocacy Development (LEAD) program.
LEAD grants support grassroots advocacy efforts by organizations committed to helping people with rare diseases who use plasma-derived and recombinant therapies to manage their health conditions. CSL Behring, a global leader in the plasma protein biotherapeutics industry, awards LEAD grants semiannually.
